Pfizer vaccine to generate $26 billion in revenue this year

Pfizer, an American pharmaceutical corporation, said on Tuesday that it expects its COVID-19 vaccine to generate $26 billion in revenue in 2021, up from its previous estimate of $15 billion.

 

According to the New York Times, the vaccine grossed $3.5 billion in revenue in the first three months of this year, nearly a quarter of its total revenue, the company reported.

 

Source: Jordan News Agency